FDA Inspection 1024633 — AHN Center for Reproductive Medicine
The FDA completed an inspection of AHN Center for Reproductive Medicine on August 24, 2017 in Pittsburgh, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 24, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Pittsburgh, PA (United States)